Cost-effectiveness of non-surgical periodontal therapy for patients with type 2 diabetes in the UK.
Josephine Solowiej-WedderburnMark IdeMark W PenningtonPublished in: Journal of clinical periodontology (2017)
Assuming improvements in glycated haemoglobin can be maintained, periodontal therapy may be cost-effective for patients with type 2 diabetes at acceptable cost-per-Quality Adjusted Life-Year thresholds in the UK.